This article is authored by Dr YK Gupta, president, AIIMS, Jammu and Ankush Kapoor, founder & CEO, Pharma NXT Biotech.

Eli Lilly is a giant pharma company of America. This company has launched its blockbuster medicine for diabetes and obesity in India. Crores of people in India are suffering from the problem of ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Eli Lilly (LLY) launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk (NVO) for a ...

India’s biggest pharma company said in a press release filed with the stock exchanges in Mumbai on March 10. The deal will bring Unloxcyt (cosibelimab-ipdl), the first and only FDA-approved anti ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

Swiss pharmaceutical company Novartis is staying put at its Midtown office right next to Bryant Park. “We worked closely with Novartis to secure a new lease extension that addressed the firm’s current ...

Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma's specialty portfolio ...

Sun Pharma will acquire Checkpoint Therapeutics for $4.10 per share, with a potential additional $0.70 CVR. FDA-approved Unloxcyt (cosibelimab-ipdl) for metastatic or locally advanced cSCC in ...